Dr. Zhu Pirot, Ph.D.
Dr. Zhu Zhen Pirot is the head of analytical development at Sangamo Therapeutics. She currently leads the analytical team to develop methods for product characterization and release in support company’s gene editing, gene & cell therapy programs. She has extended experience and knowledge in AAV gene therapy development from early 2000 at Avigen. Her industry experience also includes cancer drug discovery & development at Chiron /Novartis, and bioanalytical assay & biomarker development at Geron Corp. She was trained as Medical Doctor in China and gained Ph.D. in cell & molecular biology from University of Turin in Italy.